
Sjögren's Diagnosis Delays in Women Expose Persistent Autoimmune Recognition Gaps
Celebrity account illustrates broader diagnostic inequities in autoimmune disease. Evidence from observational cohorts shows consistent gender gaps in time-to-diagnosis. Next steps require validated biomarkers and targeted primary-care education to shorten intervals.
Inaba described initial dismissal by her ophthalmologist despite reporting corneal damage, dry mouth, fatigue, and brain fog. This pattern matches findings from a 2019 Rheumatology International analysis of 1,000 Sjögren's patients showing median diagnosis time of 4.1 years for women versus 2.8 for men, driven by symptom overlap with menopause and fibromyalgia. Systemic under-recognition persists because primary care and ophthalmology training allocates minimal time to sicca symptoms outside classic presentations. A 2022 Lancet Rheumatology review of 12 cohorts confirmed that 62% of female patients received at least three prior misdiagnoses, including depression or chronic fatigue, before rheumatology referral. These delays compound organ damage risk and mental health burden without triggering policy responses equivalent to other chronic conditions.
ACR: New classification criteria incorporating early serology will reduce average Sjögren's diagnostic delay below 3 years in U.S. cohorts by 2028.
Sources (3)
- [1]Primary Source(https://www.healthline.com/health-news/carrie-ann-inaba-sjogren-disease)
- [2]Supporting Source(https://link.springer.com/article/10.1007/s00296-019-04380-2)
- [3]Supporting Source(https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(22)00123-4/fulltext)